Study Shows European Biotech Investments Lagging Behind U.S.
By Peter O'Donnell
Wednesday, September 26, 2007
BRUSSELS, Belgium - European biotechnology companies are being outpaced by their U.S. competitors in research investments and in the scale of their operations, according to a new study from the European Union. (BioWorld International)
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.